苯并异硒唑酮膦酸盐衍生物的合成及其对幽门螺杆菌细胞的抗溶尿作用。

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL
Marta Grabarek,Wojciech Tabor,Paweł Krzyżek,Julia Bąkowicz,Agnieszka Grabowiecka,Łukasz Berlicki,Artur Mucha
{"title":"苯并异硒唑酮膦酸盐衍生物的合成及其对幽门螺杆菌细胞的抗溶尿作用。","authors":"Marta Grabarek,Wojciech Tabor,Paweł Krzyżek,Julia Bąkowicz,Agnieszka Grabowiecka,Łukasz Berlicki,Artur Mucha","doi":"10.1021/acs.jmedchem.5c01385","DOIUrl":null,"url":null,"abstract":"The attachment of a nickel-ion-complexing functionality to the structures of covalent inhibitors of ureases has been considered an effective method for enhancing binding to these pivotal virulence factors of various microbial pathogens. Following this approach, we envisioned a structural combination of 1,2-benzisoselenazol-3(2H)-one, a scaffold that produced the most significant antiureolytic effect achieved, with a phosphonic acid group intended to block the function of nickel ions in the catalytic mechanism. The multistep preparation of hybrid compounds involved aminolysis of 2-(chloroseleno)benzoyl chloride with the key diethyl aminophosphonate intermediates, followed by hydrolysis of the final phosphonate esters. Although not entirely consistent with the rationale of the design idea, the esters themselves, rather than the corresponding acids, demonstrated more substantial inactivation of the model Sporosarcina pasteurii urease and inhibition of ureolysis in Helicobacter pylori. In particular, IC50 values in pathogen cells reached an unprecedented range of 30-40 nM for some compounds.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"38 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Synthesis of Phosphonate Derivatives of Benzisoselenazolones and Their Remarkable Antiureolytic Activity in Helicobacter pylori Cells.\",\"authors\":\"Marta Grabarek,Wojciech Tabor,Paweł Krzyżek,Julia Bąkowicz,Agnieszka Grabowiecka,Łukasz Berlicki,Artur Mucha\",\"doi\":\"10.1021/acs.jmedchem.5c01385\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The attachment of a nickel-ion-complexing functionality to the structures of covalent inhibitors of ureases has been considered an effective method for enhancing binding to these pivotal virulence factors of various microbial pathogens. Following this approach, we envisioned a structural combination of 1,2-benzisoselenazol-3(2H)-one, a scaffold that produced the most significant antiureolytic effect achieved, with a phosphonic acid group intended to block the function of nickel ions in the catalytic mechanism. The multistep preparation of hybrid compounds involved aminolysis of 2-(chloroseleno)benzoyl chloride with the key diethyl aminophosphonate intermediates, followed by hydrolysis of the final phosphonate esters. Although not entirely consistent with the rationale of the design idea, the esters themselves, rather than the corresponding acids, demonstrated more substantial inactivation of the model Sporosarcina pasteurii urease and inhibition of ureolysis in Helicobacter pylori. In particular, IC50 values in pathogen cells reached an unprecedented range of 30-40 nM for some compounds.\",\"PeriodicalId\":46,\"journal\":{\"name\":\"Journal of Medicinal Chemistry\",\"volume\":\"38 1\",\"pages\":\"\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acs.jmedchem.5c01385\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.5c01385","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

将镍离子络合功能连接到脲酶共价抑制剂的结构上,被认为是增强与各种微生物病原体的关键毒力因子结合的有效方法。根据这种方法,我们设想了1,2-苯并异硒唑-3(2H)- 1的结构组合,这是一种产生最显著的抗尿溶作用的支架,与膦酸基团旨在阻断镍离子在催化机制中的功能。杂化化合物的多步骤制备包括用关键的氨基膦酸二乙酯中间体氨解2-(氯硒)苯甲酰氯,然后水解最终的膦酸酯。尽管与设计思想的基本原理不完全一致,但酯类本身,而不是相应的酸类,显示出更显著的模型巴氏孢杆菌脲酶失活和幽门螺杆菌解尿的抑制作用。特别是,某些化合物在病原体细胞中的IC50值达到了前所未有的30-40 nM。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Synthesis of Phosphonate Derivatives of Benzisoselenazolones and Their Remarkable Antiureolytic Activity in Helicobacter pylori Cells.
The attachment of a nickel-ion-complexing functionality to the structures of covalent inhibitors of ureases has been considered an effective method for enhancing binding to these pivotal virulence factors of various microbial pathogens. Following this approach, we envisioned a structural combination of 1,2-benzisoselenazol-3(2H)-one, a scaffold that produced the most significant antiureolytic effect achieved, with a phosphonic acid group intended to block the function of nickel ions in the catalytic mechanism. The multistep preparation of hybrid compounds involved aminolysis of 2-(chloroseleno)benzoyl chloride with the key diethyl aminophosphonate intermediates, followed by hydrolysis of the final phosphonate esters. Although not entirely consistent with the rationale of the design idea, the esters themselves, rather than the corresponding acids, demonstrated more substantial inactivation of the model Sporosarcina pasteurii urease and inhibition of ureolysis in Helicobacter pylori. In particular, IC50 values in pathogen cells reached an unprecedented range of 30-40 nM for some compounds.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信